Jennifer E Flythe1,2, Julia H Narendra1, Christina Yule3, Surya Manivannan1, Shannon Murphy1, Shoou-Yih D Lee4, Tara S Strigo5, Sarah Peskoe6, Jane F Pendergast6, L Ebony Boulware5, Jamie A Green3,7. 1. University of North Carolina (UNC) Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina. 2. Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, North Carolina. 3. Kidney Health Research Institute, Geisinger, Danville, Pennsylvania. 4. Department of Health Administration, College of Health Professions, Virginia Commonwealth University, Richmond, Virginia. 5. Division of General Internal Medicine, Duke University School of Medicine, Durham, North Carolina. 6. Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina. 7. Department of Nephrology, Geisinger Commonwealth School of Medicine, Danville, Pennsylvania.
Abstract
Background: Guidelines recommend pre-emptive creation of arteriovenous (AV) access. However, <20% of US patients initiate hemodialysis (HD) with a functional AV access. We implemented a quality improvement (QI) program to improve pre-HD vascular access care. Methods: After conducting qualitative research with key informants, we implemented a 7-month vascular access support QI program at Geisinger Health. The program targeted patient and health system barriers to AV access through education, needs assessment, peer support, care navigation, and electronic supports. We performed pre-, intra-, and postprogram stakeholder interviews to identify program barriers and facilitators and to assess acceptability. In a research substudy, we compared pre- and postprogram self-efficacy, knowledge, and confidence navigating vascular access care. Results: There were 37 patient and 32 clinician/personnel participants. Of the 37 patients, 34 (92%) completed vascular access-specific education, 33 (89%) underwent needs assessment, eight (22%) engaged with peer mentors, 21 (57%) had vein mapping, 18 (49%) had an initial surgical appointment, 15 (40%) underwent AV access surgery, and six (16%) started HD during the 7-month program. Qualitative findings demonstrated program acceptability to participants and suggested that education provision and emotional barrier identification were important to engaging patients in vascular access care. Research findings showed pre- to postprogram improvements in patient self-efficacy (28.1-30.8, P=0.05) and knowledge (4.9-6.9, P=0.004), and trends toward improvements in confidence among patients (8.0-8.7, P=0.2) and providers (7.5-7.8, P=0.1). Conclusions: Our intervention targeting patient and health system barriers improved patient vascular access knowledge and self-efficacy. Clinical Trial registry name and registration number: Breaking Down Care Process and Patient-level Barriers to Arteriovenous Access Creation Prior to Hemodialysis Initiation, NCT04032613.
Background: Guidelines recommend pre-emptive creation of arteriovenous (AV) access. However, <20% of US patients initiate hemodialysis (HD) with a functional AV access. We implemented a quality improvement (QI) program to improve pre-HD vascular access care. Methods: After conducting qualitative research with key informants, we implemented a 7-month vascular access support QI program at Geisinger Health. The program targeted patient and health system barriers to AV access through education, needs assessment, peer support, care navigation, and electronic supports. We performed pre-, intra-, and postprogram stakeholder interviews to identify program barriers and facilitators and to assess acceptability. In a research substudy, we compared pre- and postprogram self-efficacy, knowledge, and confidence navigating vascular access care. Results: There were 37 patient and 32 clinician/personnel participants. Of the 37 patients, 34 (92%) completed vascular access-specific education, 33 (89%) underwent needs assessment, eight (22%) engaged with peer mentors, 21 (57%) had vein mapping, 18 (49%) had an initial surgical appointment, 15 (40%) underwent AV access surgery, and six (16%) started HD during the 7-month program. Qualitative findings demonstrated program acceptability to participants and suggested that education provision and emotional barrier identification were important to engaging patients in vascular access care. Research findings showed pre- to postprogram improvements in patient self-efficacy (28.1-30.8, P=0.05) and knowledge (4.9-6.9, P=0.004), and trends toward improvements in confidence among patients (8.0-8.7, P=0.2) and providers (7.5-7.8, P=0.1). Conclusions: Our intervention targeting patient and health system barriers improved patient vascular access knowledge and self-efficacy. Clinical Trial registry name and registration number: Breaking Down Care Process and Patient-level Barriers to Arteriovenous Access Creation Prior to Hemodialysis Initiation, NCT04032613.
Authors: Sankar D Navaneethan; Stacey E Jolly; Jesse D Schold; Susana Arrigain; Georges Nakhoul; Victoria Konig; Jennifer Hyland; Yvette K Burrucker; Priscilla Davis Dann; Barbara H Tucky; John Sharp; Joseph V Nally Journal: Clin J Am Soc Nephrol Date: 2017-08-04 Impact factor: 8.237
Authors: Sidney Glazer; Jean Diesto; Peter Crooks; Hock Yeoh; Noel Pascual; David Selevan; Stephen Derose; Michael Farooq Journal: Ann Vasc Surg Date: 2006-01 Impact factor: 1.466
Authors: Pietro Ravani; Suetonia C Palmer; Matthew J Oliver; Robert R Quinn; Jennifer M MacRae; Davina J Tai; Neesh I Pannu; Chandra Thomas; Brenda R Hemmelgarn; Jonathan C Craig; Braden Manns; Marcello Tonelli; Giovanni F M Strippoli; Matthew T James Journal: J Am Soc Nephrol Date: 2013-02-21 Impact factor: 10.121
Authors: Navdeep Tangri; Morgan E Grams; Andrew S Levey; Josef Coresh; Lawrence J Appel; Brad C Astor; Gabriel Chodick; Allan J Collins; Ognjenka Djurdjev; C Raina Elley; Marie Evans; Amit X Garg; Stein I Hallan; Lesley A Inker; Sadayoshi Ito; Sun Ha Jee; Csaba P Kovesdy; Florian Kronenberg; Hiddo J Lambers Heerspink; Angharad Marks; Girish N Nadkarni; Sankar D Navaneethan; Robert G Nelson; Stephanie Titze; Mark J Sarnak; Benedicte Stengel; Mark Woodward; Kunitoshi Iseki Journal: JAMA Date: 2016-01-12 Impact factor: 56.272
Authors: Charmaine E Lok; Thomas S Huber; Timmy Lee; Surendra Shenoy; Alexander S Yevzlin; Kenneth Abreo; Michael Allon; Arif Asif; Brad C Astor; Marc H Glickman; Janet Graham; Louise M Moist; Dheeraj K Rajan; Cynthia Roberts; Tushar J Vachharajani; Rudolph P Valentini Journal: Am J Kidney Dis Date: 2020-03-12 Impact factor: 8.860
Authors: Jordan R Casey; Camilla S Hanson; Wolfgang C Winkelmayer; Jonathan C Craig; Suetonia Palmer; Giovanni F M Strippoli; Allison Tong Journal: Am J Kidney Dis Date: 2014-08-10 Impact factor: 8.860
Authors: Michael Allon; Lesley Dinwiddie; Eduardo Lacson; Derrick L Latos; Charmaine E Lok; Theodore Steinman; Daniel E Weiner Journal: J Am Soc Nephrol Date: 2011-02-18 Impact factor: 10.121
Authors: Pietro Ravani; Brenda W Gillespie; Robert Ross Quinn; Jennifer MacRae; Braden Manns; David Mendelssohn; Marcello Tonelli; Brenda Hemmelgarn; Matthew James; Neesh Pannu; Bruce M Robinson; Xin Zhang; Ronald Pisoni Journal: J Am Soc Nephrol Date: 2013-07-11 Impact factor: 10.121